Guardant Health Inc (GH): Next-Year EPS Estimate 31.91%
As of 2026-06-11, Guardant Health Inc (GH) has a next-year EPS growth estimate of 31.91%.
On 2026-06-08, analyst consensus for GH's next-year EPS growth shifted from 31.21% to 31.91% — a positive change of 0.70 percentage points. The revised estimate has been sustained across 4 subsequent trading sessions. Current-year growth is projected at 11.65%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- EPS growth next year
- 31.91%
- EPS growth this year
- 11.65%
- EPS next quarter (est)
- -$0.75
- Last price
- $130.90
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-11 | 31.91% | 11.65% | -$0.75 | $130.90 |
| 2026-06-10 | 31.91% | 11.65% | -$0.75 | $130.70 |
| 2026-06-09 | 31.91% | 11.65% | -$0.75 | $130.12 |
| 2026-06-08 | 31.91% | 11.65% | -$0.75 | $124.89 |
| 2026-06-07 | 31.21% | 11.72% | -$0.75 | $125.61 |
| 2026-06-04 | 31.21% | 11.72% | -$0.75 | $133.06 |
| 2026-06-03 | 31.21% | 11.72% | -$0.75 | $127.03 |
| 2026-06-02 | 31.21% | 11.72% | -$0.75 | $130.17 |
| 2026-06-01 | 31.21% | 11.72% | -$0.75 | $129.14 |
| 2026-05-31 | 31.21% | 11.72% | -$0.75 | $129.69 |
| 2026-05-28 | 31.21% | 11.72% | -$0.75 | $133.22 |
| 2026-05-27 | 31.21% | 11.72% | -$0.75 | $127.51 |
| 2026-05-26 | 31.20% | 11.73% | -$0.75 | $119.85 |
| 2026-05-25 | 32.09% | 11.78% | -$0.76 | $118.95 |
| 2026-05-24 | 32.09% | 11.78% | -$0.76 | $118.95 |
| 2026-05-21 | 32.09% | 11.78% | -$0.76 | $118.01 |
| 2026-05-20 | 32.09% | 11.78% | -$0.76 | $114.97 |
| 2026-05-19 | 32.09% | 11.78% | -$0.76 | $98.19 |
| 2026-05-18 | 32.09% | 11.78% | -$0.76 | $95.66 |
| 2026-05-17 | 32.09% | 11.78% | -$0.76 | $94.92 |
| 2026-05-14 | 32.09% | 11.78% | -$0.76 | $98.66 |
| 2026-05-13 | 32.27% | 11.75% | -$0.76 | $97.70 |
| 2026-05-12 | 31.95% | 11.72% | -$0.76 | $99.94 |
| 2026-05-11 | 31.76% | 11.57% | -$0.76 | $96.71 |
| 2026-05-10 | 32.33% | 11.27% | -$0.76 | $95.70 |
| 2026-05-07 | 35.47% | 10.84% | -$0.81 | $92.26 |
| 2026-05-06 | 35.47% | 10.84% | -$0.81 | $92.25 |
| 2026-05-05 | 35.47% | 10.84% | -$0.81 | $89.52 |
| 2026-05-04 | 35.47% | 10.84% | -$0.81 | $91.17 |
| 2026-05-03 | 35.47% | 10.84% | -$0.81 | $87.60 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Guardant Health Inc's next-year EPS growth estimate?▾
As of 2026-06-11, Guardant Health Inc (GH) has a next-year EPS growth estimate of 31.91%, based on analyst consensus.
When was the latest EPS estimate revision for GH?▾
The most recent revision occurred on 2026-06-08, when analysts adjusted the next-year EPS growth estimate from 31.21% to 31.91%.
What sector and industry does Guardant Health Inc belong to?▾
Guardant Health Inc operates in the Healthcare sector, specifically the Diagnostics & Research industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. GH appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Guardant Health Inc (GH) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports